|
HY-100007-100mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-100007-250mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-10010-10mg
|
MedChemexpress LLC
|
Ko 143 [CAS 461054-93-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10010-100mg
|
MedChemexpress LLC
|
Ko 143 [CAS 461054-93-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10010-25mg
|
MedChemexpress LLC
|
Ko 143 [CAS 461054-93-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10010-5mg
|
MedChemexpress LLC
|
Ko 143 [CAS 461054-93-3]
|
|
Cancer-programmed cell death
|
|
|
HY-10010-50mg
|
MedChemexpress LLC
|
Ko 143 [CAS 461054-93-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100403-10mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100403-100mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100403-2mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100403-25mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100403-5mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100403-50mg
|
MedChemexpress LLC
|
Ro 67-7476 [CAS 298690-60-5]
|
|
Cancer-programmed cell death
|
|
|
HY-10053-10mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10053-100mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10053-25mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10053-5mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10053-50mg
|
MedChemexpress LLC
|
Maropitant [CAS 147116-67-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100609-10mg
|
MedChemexpress LLC
|
4-P-PDOT [CAS 134865-74-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100609-100mg
|
MedChemexpress LLC
|
4-P-PDOT [CAS 134865-74-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100609-5mg
|
MedChemexpress LLC
|
4-P-PDOT [CAS 134865-74-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100609-50mg
|
MedChemexpress LLC
|
4-P-PDOT [CAS 134865-74-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100750-10mg
|
MedChemexpress LLC
|
Norverapamil (hydrochloride) [CAS 67812-42-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100750-2mg
|
MedChemexpress LLC
|
Norverapamil (hydrochloride) [CAS 67812-42-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100750-25mg
|
MedChemexpress LLC
|
Norverapamil (hydrochloride) [CAS 67812-42-4]
|
|
COVID-19-immunoregulation
|
|
